MICHAEL REUTTER: Open Payments
NPI 1639407414 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 112 payments from 27 companies in 2025. Trend: 2023 $1,455 · 2024 $1,363 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $180 |
| Amgen Inc. | 19 | $180 |
| Kowa Pharmaceuticals America, Inc. | 12 | $145 |
| Otsuka America Pharmaceutical, Inc. | 7 | $125 |
| Ardelyx, Inc. | 6 | $120 |
| Lundbeck LLC | 5 | $98 |
| ABBVIE INC. | 5 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
Products named: REXULTI, ZORYVE, OMVOH, IBSRELA, EVENITY, OTEZLA, FANAPT, Kerendia.
Industry payments across NJ — which companies pay providers there.
